Nfibra Competitors

Na Claro, ajudamos as empresas e o Estado a simplificar a forma como comunicam. Para se fazerem entender e ficarem mais perto das pessoas. Tornamos mais simples o que é complexo – seja um site, um email de apoio ao cliente, um manual de instruções, uma fatura, uma app, um formulário, um contrato, as condições de um serviço ou uma lei. Porque o que é complexo não precisa de ser complicado.

Luzitin, S.A. is a pharmaceutical company focused on the pursuit of innovative solutions for photodynamic therapy (PDT) and photodiagnosis (PDD). Luzitin is open to different investment modalities, from equity sharing to licensing and/or co-development of its therapeutic solutions. There are three unique opportunities for partnership development of Redaporfin: Redaporfin combined with immune checkpoint inhibitors based on its meaningful in-vivo preclinical immunologic effects to treat melanoma. | Redaporfin to treat biliary tract cancer for which EMA has granted Orphan Drug Designation and for which a pivotal study is planned. This provides a further opportunity for fast track status. Application for Orphan Drug Designation by the FDA is planned for later in 2016. | Redaporfin to treat head and neck cancer in combination with immune checkpoint inhibitors.

IBERFIBRAN is a Portuguese high quality extruded polystyrene (XPS) producer. The company produces Thermal Insulation boards of high thickness and dimensions, under FIBRANxps brand. IBERFIBRAN is part of FIBRAN Group which is oriented to systemic solutions. FIBRANxps, FIBRANgeo and FIBRANgyps brands are well positioned on the markets all over the Europe and wider and some of them constantly present at over 40 markets. Contact us: iberfibran@iberfibran.pt